Eli Lilly picks Virginia for $5bn drug manufacturing plant
The API and drug product facility is the first of four new manufacturing plants set to be built by Eli Lilly in the US over the next five years.
Drug Manufacturers
Opadry complete film coating system: 45 years of trust, innovation and performance
J&J signs $2bn incumbency deal at CDMO Fujifilm’s new hub
Trump targets bolstering of US emergency drug reserve
Uncertainty looms over FDA scheme to boost US manufacturing
Manufacturing issues at Novo facility disrupt Regeneron drug review
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing
Solid tumours: CAR-T therapies’ Waterloo
